Approvals/TGA/KISQALI ribociclib 200 mg (as succinate) film coated tablet blister pack

Approved

STANDARD

KISQALI ribociclib 200 mg (as succinate) film coated tablet blister pack

Approval Id: 7ebb1d5fedf91273
Product Name: KISQALI ribociclib 200 mg (as succinate) film coated tablet blister pack
Artg Id: 280246
Artg Name: KISQALI ribociclib 200 mg (as succinate) film coated tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2017-10-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/27f6399a80eb348b0e5130e10bedbac4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ebdf68d86d58c365ec56168c79776b7c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7ebb1d5fedf91273

Type

Standard